| lisdexamfetamine / Generic mfg. |
| Recruiting | 4 | 62 | | | University of Sydney, Shire International GmbH | Binge-Eating Disorder | | | | |
NCT00500071: Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD |
|
|
| Completed | 4 | 318 | US | Vyvanse (lisdexamfetamine dimesylate) | Shire | Attention Deficit Hyperactivity Disorder (ADHD) | 01/08 | 01/08 | | |
| Completed | 4 | 42 | US | Vyvanse, lisdexamfetamine dimesylate | Kimberley Lakes, Shire | Attention Deficit/Hyperactivity Disorder | 09/09 | 09/09 | | |
NCT00889915: Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study) |
|
|
| Completed | 4 | 228 | US | Methylphenidate transdermal system, Daytrana, Lisdexamfetamine dimesylate, Vyvanse, Osmotic-release oral system methylphenidate (OROS MPH), Concerta, Mixed amphetamine salts extended release, Adderall XR | Duke University, National Institute of Mental Health (NIMH) | Attention Deficit Disorder With Hyperactivity | 12/09 | 12/09 | | |
NCT00573534: Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse |
|
|
| Completed | 4 | 8 | US | Vyvanse, Lisdexamphetamine is marketed as Vyvanse | New York State Psychiatric Institute | Attention Deficit Hyperactivity Disorder | 01/10 | 03/10 | | |
NCT00801229: Effect of Vyvanse on Driving in Young Adults With ADHD |
|
|
| Completed | 4 | 75 | US | Vyvanse, Lisdexamfetamine, Placebo | Massachusetts General Hospital, Shire | Attention Deficit/Hyperactivity Disorder(ADHD) | 07/10 | 07/10 | | |
NCT00877487: Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder |
|
|
| Completed | 4 | 123 | US | SPD489 (Lisdexamfetamine dimesylate), Vyvanse, Placebo | Shire | Attention-Deficit/Hyperactivity Disorder | 07/10 | 07/10 | | |
NCT01101022: Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 161 | US | SPD489, Vyvanse, Placebo | Shire | ADHD Specifically With Executive Function Impairment | 11/10 | 11/10 | | |
NCT01342445: Effects of LDX on Functioning of College Students With ADHD |
|
|
| Completed | 4 | 50 | US | lisdexamfetamine dimesylate, Vyvanse, LDX, Placebo | University of Rhode Island, Lehigh University | Attention-deficit/Hyperactivity Disorder | 12/10 | 12/10 | | |
NCT00753012: Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults |
|
|
| Completed | 4 | 24 | US | Lisdexamfetamine, Vyvanse | Massachusetts General Hospital, Shire | Attention Deficit Hyperactivity Disorder (ADHD) | 03/11 | 03/11 | | |
NCT01051440: Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression |
|
|
| Terminated | 4 | 2 | US | Lisdexamfetamine, Vyvanse, Placebo | Steward St. Elizabeth's Medical Center of Boston, Inc., Shire | Bipolar Depression | 06/11 | 06/11 | | |
NCT01070394: Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse) |
|
|
| Completed | 4 | 40 | US | LDX Treatment, Vyvanse | NYU Langone Health, Shire | Attention Deficit Hyperactivity Disorder | 07/12 | 07/12 | | |
NCT01127607: Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance? |
|
|
| Completed | 4 | 38 | US | lisdexamfetamine, vyvanse | Florida International University | ADHD | 07/12 | 07/12 | | |
NCT01017263: Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity |
|
|
| Terminated | 4 | 14 | US | Lis-dexamphetamine, Vyvanse, LDX | Duke University, Shire | Attention Deficit Hyperactivity Disorder, Glucose Intolerance, Obesity | 08/12 | 08/12 | | |
NCT01413165: Phase 4, Open Label, Multicentre, 2 Year Safety Study of Lisdexamfetamine Dimesylate in Children/Adolescents With ADHD |
|
|
| Not yet recruiting | 4 | 12 | Europe | Lisdexamfetamine dimesylate, SPD 489 | Maastricht University Medical Center, Shire Development LLC | Attention Deficit Disorder With Hyperactivity | 08/13 | 12/13 | | |
NCT01924429: Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation |
|
|
| Completed | 4 | 30 | US | Lisdexamfetamine, Vyvanse | Jeffrey Newcorn | ADHD | 12/13 | 12/13 | | |
NCT01552915: Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder |
|
|
| Completed | 4 | 464 | US | Lisdexamfetamine dimesylate, LDX, Vyvanse, SPD489, Methylphenidate Hydrochloride, OROS-MPH, Concerta, Placebo | Shire | Attention-deficit/Hyperactivity Disorder | 01/14 | 01/14 | | |
NCT01324024: Attention & Memory Impairments in Menopausal Women |
|
|
| Completed | 4 | 35 | US | Lisdexamfetamine, Vyvanse®, Placebo | University of Pennsylvania, Shire | Symptomatic Menopause, Cognitive Impairments | 04/14 | 04/14 | | |
| Completed | 4 | 549 | Europe, Canada, US | Lisdexamfetamine dimesylate, SPD489, Vyvanse, LDX, Methylphenidate Hydrochloride, Concerta, OROS-MPH, Placebo | Shire | Attention-deficit/Hyperactivity Disorder | 05/14 | 05/14 | | |
NCT01148979: Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder. |
|
|
| Completed | 4 | 35 | US | Lisdexamfetamine Dimesylate (Vyvanse), Vyvanse, Placebo, Sugar pill | Mclean Hospital, Shire | Major Depressive Disorder | 09/14 | 10/14 | | |
NCT01328756 / 2010-020951-30: Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) |
|
|
| Completed | 4 | 314 | Europe | Lisdexamfetamine dimesylate, Vyvanse, SPD489, LDX | Shire | Attention Deficit Hyperactivity Disorder (ADHD) | 09/14 | 09/14 | | |
| Terminated | 4 | 6 | US | Lisdexamfetamine, Vyvanse | University of California, Davis, Shire | Attention Deficit Hyperactivity Disorder | 06/15 | 06/15 | | |
NCT02204410: Omega-3 Supplementation to ADHD Medication in Children |
|
|
| Completed | 4 | 21 | US | Omega-3 Fatty Acid, Fish Oil, Nordic Naturals Pro-Omega Junior Omega-3 Fatty Acid, Nordic Omega-3 Fishies, ADHD Medication, Stimulant, Concerta, Ritalin, Focalin, Vyvanse, Adderall, Dexedrine, Amphetamine, Methylphenidate, Stratterra, Tenex | Massachusetts General Hospital | Attention Deficit Hyperactivity Disorder, Deficient Emotional Self-Regulation | 05/16 | 08/16 | | |
TMF, NCT01816074: Sequencing Treatments for Mothers With ADHD and Their At - Risk Children |
|
|
| Completed | 4 | 53 | US | Vyvanse (lisdexamphetamine), Lisdexamfetamine, Behavior Parent Training, BPT | Seattle Children's Hospital, Shire | Attention Deficit Hyperactivity Disorder | 10/16 | 05/17 | | |
NCT01863459: Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity |
|
|
| Completed | 4 | 42 | Canada | Lisdexamfetamine Dimesylate, Vyvanse, placebo | Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada, Shire | Adult Attention Deficit Hyperactivity Disorder (ADHD) With Co-occuring Anxiety and Depressive Disorders | 03/17 | 03/17 | | |
2017-000368-14: A clinical trial of methylphenidate and lisdexamphetamine treatment in adults with attention-deficit hyperactivity disorder En jämförande studie av metylfenidat och lisdexamfetamine hos vuxna personer med ADHD |
|
|
| Terminated | 4 | 120 | Europe | Elvanse, Concerta, Capsule, hard, Tablet, Elvanse, Concerta | Sahlgrenska Univerisity Hospital Gothenburg, Sahlgrenska University Hospital | Attention Deficit Hyperactivity Disorder aktivitets- och uppmärksamhetsstörning, Attention deficit hyperactivity disorder is a mental disorder characterized by problems paying attention, excessive activity, or difficulty controlling behavior ADHD är en neuropsykiatrisk funktionsnedsättning som utmärks av nedsatta exekutiva förmågor, exempelvis bristande förmåga att kontrollera uppmärksamheten och/eller hyperaktivitet., Psychiatry and Psychology [F] - Behaviours [F01] | | | | |
NCT02675400: Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too) |
|
|
| Completed | 4 | 19 | US | Vyvanse, lisdexamfetamine dimesylate, Behavioral Parent Training, BPT, Methylphenidate, MPH | Seattle Children's Hospital | Attention Deficit/Hyperactivity Disorder (ADHD) | 08/18 | 08/18 | | |
NCT03446885: Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD |
|
|
| Completed | 4 | 22 | US | Lisdexamfetamine Dimesylate 40 MG, Placebo | Gregory Fabiano | Attention Deficit Disorder With Hyperactivity | 02/19 | 08/19 | | |
TBIC, NCT02712996: Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children |
|
|
| Completed | 4 | 20 | US | Lisdexamfetamine, Vyvanse, Placebo | Vanderbilt University, Shire | Traumatic Brain Injury, Attention Deficit Disorder | 07/19 | 07/19 | | |
NCT02566824: Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder |
|
|
| Unknown status | 4 | 216 | Canada | Cognitive Behavioural & Skills Training, Supportive Group Therapy, Treatment as Usual - community resources, Methylphenidate or amphetamine product, Ritalin, Concerta, Biphentin, Dexedrine, Adderall XR, Vyvanse | McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR) | Attention Deficit Hyperactivity Disorder | 08/20 | 10/20 | | |
| Completed | 4 | 257 | Canada | Methylphenidate Hydrochloride, FOQUEST, ADHANSIA XR, Lisdexamfetamine Dimesylate, VYVANSE | Purdue Pharma, Canada | Attention Deficit-Hyperactivity Disorder | 07/21 | 07/21 | | |
NCT03337646: Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism |
|
|
| Completed | 4 | 48 | Canada | Lisdexamfetamine Dimesylate, Vyvanse | JPM van Stralen Medicine Professional, Shire | Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder | 03/23 | 03/23 | | |
| Recruiting | 4 | 10 | US | Stimulant, Adderall, Concerta, Aptensio, Daytrana, Metadate, Quillivant, Ritalin, Focalin, Vyvanse | Matthew J O'Brien, PhD, BCBA-D | Attention Deficit Hyperactivity Disorder, Problem Behavior | 01/25 | 01/25 | | |
